You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Biological Activity for GGTI 298
GGTI 298 is a CAAZ peptidomimetic geranylgeranyltransferase I (GGTase I) inhibitor. Strongly inhibits the processing of geranylgeranylated Rap1A with little effect on processing of farnesylated Ha-Ras (IC50 values are 3 and > 10 μM respectively). Causes G0-G1 cell cycle block and apoptosis in A549 cells and inhibits cell invasion and migration in COLO 320CM cells.
Technical Data for GGTI 298
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for GGTI 298
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions for GGTI 298
The following data is based on the product molecular weight 593.66. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.25 mM||6.74 mL||33.69 mL||67.38 mL|
|1.25 mM||1.35 mL||6.74 mL||13.48 mL|
|2.5 mM||0.67 mL||3.37 mL||6.74 mL|
|12.5 mM||0.13 mL||0.67 mL||1.35 mL|
References for GGTI 298
References are publications that support the biological activity of the product.
McGuire et al (1996) Platelet-derived growth factor receptor tyrosine kinase phosphorylation requires protein geranylgeranylation but not farnesylation. J.Biol.Chem. 271 27402 PMID: 8910319
Miquel et al (1997) GGTI-298 induces G0-G1 block and apoptosis whereas FTI-227 causes G2-M enrichment in A549 cells. Cancer Res. 57 1846 PMID: 9157972
Porcu et al (2010) A yeast-based genomic strategy highlights the cell protein networks altered by FTase inhibitor peptidomimetics. Mol.Cancer 9 197 PMID: 20653956
Kusama et al (2003) Selective inhibition of cancer cell invasion by a geranylgeranyltransferase inhibitor. Clin.Exp.Meta. 20 561
If you know of a relevant reference for GGTI 298, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: GGTI 298, GGTI 298 supplier, GGTI298, geranylgeranyltransferase, GGTase1, Protein, Prenyltransferases, Post-translational, Modifications, 2430, Tocris Bioscience
2 Citations for GGTI 298
Citations are publications that use Tocris products. Selected citations for GGTI 298 include:
Luttman et al (2021) ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells. ABL allosteric inhibitors synergize with statins to 37 109880 PMID: 34706244
Domingue et al (2016) Chenodeoxycholic Acid Requires Activation of EGFR, EPAC and Ca2+ to Stimulate CFTR-dependent Cl-Secretion in Human Colonic T84 Cells. American Journal of Physiology - Cell Physiology PMID: 27558159
Do you know of a great paper that uses GGTI 298 from Tocris? Please let us know.
Reviews for GGTI 298
Average Rating: 5 (Based on 1 Review.)
Have you used GGTI 298?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.